Christoph Schwering

Christoph Schwering is a physician specializing in Pediatrics and Youth Medicine at the University of Hamburg's Faculty of Medicine. He works at the University Medical Center Hamburg-Eppendorf (UKE), contributing to clinical research in rare neurodegenerative diseases through the Department of Pediatrics.

• Specializes in CLN2 disease (Batten disease) and related neurodevelopmental disorders
• Key contributor to developing intracerebroventricular enzyme replacement therapy guidelines
• Conducts multidisciplinary research on retinal degeneration as a biomarker for neurological progression
• Active in quality of life assessments for rare disease patients

His research focuses on CLN2 disease pathophysiology and therapeutic interventions. Recent publications examine:

• Retinal nerve fiber layer thickness as a biomarker
• Clinical management of comorbidities
• Standardization of treatment protocols
• Quality of life metrics in rare diseases

As part of UKE's Department of Pediatrics, he collaborates across neurology, ophthalmology, and pharmacology disciplines to advance care for patients with neurodegenerative conditions.